The relationship between coenzyme Q10 and severity of coronary artery disease

Medicinski Glasnik

Volumn 10, Issue 2, 2013, Pages 229-233

  Büyükkaya, Eyüp ^a   Evliyaoǧlu, Osman ^b   Islamoǧlu, Yahya ^b   Cil, Habib ^b   Karakaş, Mehmet Fatih ^a   Akçay, Adnan Burak ^a   Bilen, Perihan ^a   Kurt, Mustafa ^a   Şen, Nihat ^a   Ertas, Faruk ^b   Mete, Nuriye ^b  

^a MUSTAFA KEMAL UNIVERSITY   (Turkey)

^b DICLE UNIVERSITY   (Turkey)

Author keywords

Antioxidant; Atherosclerosis; Gensini score

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UBIDECARENONE; CHOLESTEROL;

ADULT; AGE; ANGIOCARDIOGRAPHY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY OBSTRUCTION; DIABETES MELLITUS; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; GENSINI SCORE; HEART INFARCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; STABLE ANGINA PECTORIS; BLOOD; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE;

CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; HUMANS;

EID: 84880751050     PISSN: 18400132     EISSN: 18402445     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Braunwald E, Kloner RA. Myocardial reperfusion: a double-edged sword? J Clin Invest 1985; 76:1713-9.
2. Goldhaber JI, Weiss JN. Oxygen free radicals and cardiac reperfusion abnormalities. Hypertension 1992; 20:118-27.
3. Meerson FZ, Kagan VE, Kozlov Yu P, Belkina LM, Arkhipenko Yu V. The role of lipid peroxidation in pathogenesis of ischemic damage and the antioxidant protection of the heart. Basic Res Cardiol 1982; 77:465-85.
4. Banerjee A, Grosso MA, Brown JM, Rogers KB, Whitman GJ. Oxygen metabolite effects on creatine kinase and cardiac energetics after reperfusion. Am J Physiol 1991; 261:H590-7.
5. Neubauer S, Hamman BL, Perry SB, Bittl JA, Ingwall JS. Velocity of the creatine kinase reaction decreases in postischemic myocardium: a 31P-NMR magnetization transfer study of the isolated ferret heart. Circ Res 1988; 63:1-15.
6. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989; 320:915-24.
7. Witztum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 1991; 88:1785-92.
8. Frei B, Kim MC, Ames BN. Ubiquinol-10 is an effective lipid-soluble antioxidant at physiological concentrations. Proc Natl Acad Sci U S A 1990; 87:4879-83.
9. Ernster L, Dallner G. Biochemical, physiological and medical aspects of ubiquinone function. Biochim Biophys Acta 1995; 1271:195-204.
10. Alleva R, Tomasetti M, Bompadre S, Littarru GP. Oxidation of LDL and their subfractions: kinetic aspects and CoQ10 content. Mol Aspects Med 1997; 18 (Suppl):S105-12.
11. Shargorodsky M, Debby O, Matas Z, Zimlichman R. Effect of long-term treatment with antioxidants (vitamin C, vitamin E, coenzyme Q10 and selenium) on arterial compliance, humoral factors and inflammatory markers in patients with multiple cardiovascular risk factors. Nutr Metab (Lond) 2010; 7:55.
12. Hanaki Y, Sugiyama S, Ozawa T, Ohno M. Coenzyme Q10 and coronary artery disease. Clin Investig 1993; 71:S112-5.
13. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983; 51:606.
14. Oishi Y, Wakatsuki T, Nishikado A, Oki T, Ito S. Circulating adhesion molecules and severity of coronary atherosclerosis. Coron Artery Dis 2000; 11:77-81.
15. Tei C. New non-invasive index for combined systolic and diastolic ventricular function. J Cardiol 1995; 26:135-6.
16. Kaplan P, Sebestianova N, Turiakova J, Kucera I. Determination of coenzyme Q in human plasma. Physiol Res 1996; 45:39-45.
17. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18:499-502.
18. Kagan VE, Serbinova EA, Koynova GM, Kitanova SA, Tyurin VA, Stoytchev TS, Quinn PJ, Packer L. Antioxidant action of ubiquinol homologues with different isoprenoid chain length in biomembranes. Free Radic Biol Med 1990; 9:117-26.
19. Kontush A, Finckh B, Karten B, Kohlschutter A, Beisiegel U. Antioxidant and prooxidant activity of alpha-tocopherol in human plasma and low density lipoprotein. J Lipid Res 1996; 37:1436-48.
20. Ernster L, Forsmark-Andree P. Ubiquinol: an endogenous antioxidant in aerobic organisms. Clin Investig 1993; 71:S60-5.
21. Overvad K, Diamant B, Holm L, Holmer G, Mortensen SA, Stender S. Coenzyme Q10 in health and disease. Eur J Clin Nutr 1999; 53:764-70.
22. Hughes K, Lee BL, Feng X, Lee J, Ong CN. Coenzyme Q10 and differences in coronary heart disease risk in Asian Indians and Chinese. Free Radic Biol Med 2002; 32:132-8.
23. Yalcin A, Kilinc E, Sagcan A, Kultursay H. Coenzyme Q10 concentrations in coronary artery disease. Clin Biochem 2004; 37:706-9.
24. Lee BJ, Huang YC, Chen SJ, Lin PT. Effects of coenzyme Q10 supplementation on inflammatory markers (high-sensitivity C-reactive protein, interleukin-6, and homocysteine) in patients with coronary artery disease. Nutrition 2012; 28:767-72.
25. Kovárník T, Reznícek V, Novácková K, Bělohlávek J, Horák J, Holm F, Simek S, Aschermann M. Comparison of the morphology of atherosclerotic plaques in patients with stable angina pectoris and acute coronary syndrome using intravascular ultrasonography. Cas Lek Cesk. 2003; 142:461-4.
26. Singh RB, Neki NS, Kartikey K, Pella D, Kumar A, Niaz MA, Thakur AS. Effect of coenzyme Q10 on risk of atherosclerosis in patients with recent myocardial infarction. Mol Cell Biochem 2003; 246:75-82.